Purchase Order 75N95023P00582

Award Date 8/21/23
Potential Completion Date 8/20/27
Potential Value $168K
Contracting Federal Agency
National Institute on Drug Abuse
Ultimate Awardee
Bruker Corporation
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Spain
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Clinger Cohen Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed

This is a firm-fixed price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences to the foreign-owned, for-profit company Mestrelab Research SL. The award, valued at $168,213.65, is for the renewal of the Mnova NMR/LC/MS software license, a proprietary software currently in use at the agency. The software is integral to the identification, validation, and purity analysis of various chemical compounds and is used daily by the agency's chemists. The contract has a performance period of August 21, 2023 through August 20, 2027, with four 1-year option periods. No set-aside designation was used for this award. Mestrelab Research SL is a subsidiary of the Bruker Corporation.

Generated 4/11/24, 9:53 AM